Ramsay Stattman Vela & Price Inc. Acquires 970 Shares of Zimmer Biomet Holdings, Inc. (ZBH)

Ramsay Stattman Vela & Price Inc. increased its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 2.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 33,860 shares of the medical equipment provider’s stock after acquiring an additional 970 shares during the quarter. Ramsay Stattman Vela & Price Inc.’s holdings in Zimmer Biomet Holdings were worth $3,965,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the company. Longview Partners Guernsey LTD increased its holdings in shares of Zimmer Biomet Holdings by 17.7% in the 3rd quarter. Longview Partners Guernsey LTD now owns 7,506,684 shares of the medical equipment provider’s stock valued at $878,958,000 after acquiring an additional 1,128,973 shares during the period. Heritage Investors Management Corp increased its holdings in shares of Zimmer Biomet Holdings by 5.8% in the 3rd quarter. Heritage Investors Management Corp now owns 117,806 shares of the medical equipment provider’s stock valued at $13,794,000 after acquiring an additional 6,510 shares during the period. K.J. Harrison & Partners Inc increased its holdings in shares of Zimmer Biomet Holdings by 28.6% in the 3rd quarter. K.J. Harrison & Partners Inc now owns 9,000 shares of the medical equipment provider’s stock valued at $1,054,000 after acquiring an additional 2,000 shares during the period. Victory Capital Management Inc. increased its holdings in shares of Zimmer Biomet Holdings by 408.9% in the 3rd quarter. Victory Capital Management Inc. now owns 137,769 shares of the medical equipment provider’s stock valued at $16,131,000 after acquiring an additional 110,697 shares during the period. Finally, Lee Danner & Bass Inc. increased its holdings in shares of Zimmer Biomet Holdings by 16.4% in the 3rd quarter. Lee Danner & Bass Inc. now owns 12,798 shares of the medical equipment provider’s stock valued at $1,499,000 after acquiring an additional 1,800 shares during the period. 85.26% of the stock is currently owned by institutional investors and hedge funds.

A number of equities analysts have recently commented on the stock. Stifel Nicolaus reaffirmed a “hold” rating and issued a $125.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Gabelli assumed coverage on shares of Zimmer Biomet Holdings in a report on Thursday, August 24th. They issued a “buy” rating and a $142.00 target price on the stock. Zacks Investment Research cut shares of Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 8th. SunTrust Banks, Inc. reaffirmed a “buy” rating and issued a $136.00 target price on shares of Zimmer Biomet Holdings in a report on Monday, October 2nd. Finally, BMO Capital Markets reaffirmed a “buy” rating and issued a $136.00 target price on shares of Zimmer Biomet Holdings in a report on Tuesday, July 11th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $136.55.

COPYRIGHT VIOLATION NOTICE: This story was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://sportsperspectives.com/2017/11/01/ramsay-stattman-vela-price-inc-acquires-970-shares-of-zimmer-biomet-holdings-inc-zbh.html.

Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) traded down 4.46% during midday trading on Wednesday, hitting $116.19. 2,613,827 shares of the company’s stock traded hands. The company has a 50 day moving average of $118.31 and a 200 day moving average of $120.47. Zimmer Biomet Holdings, Inc. has a 52 week low of $95.63 and a 52 week high of $133.49. The stock has a market cap of $23.49 billion, a P/E ratio of 33.09 and a beta of 1.19.

Zimmer Biomet Holdings (NYSE:ZBH) last released its quarterly earnings results on Monday, October 30th. The medical equipment provider reported $1.72 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The business had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.83 billion. During the same period in the previous year, the company posted $1.79 EPS. The company’s revenue for the quarter was down .8% compared to the same quarter last year. On average, equities analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.23 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 22nd were paid a $0.24 dividend. The ex-dividend date was Thursday, September 21st. This represents a $0.96 annualized dividend and a dividend yield of 0.79%. Zimmer Biomet Holdings’s payout ratio is 27.59%.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply